l General Information |
Product Name | Cefprozil |
General description | Cefprozil is a semi-synthetic cephalosporin and a beta-lactam antibiotic with bactericidal activity. |
Synonym | (6R,7R)-7-[[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino]-8-oxo-3-[(E)-prop-1-enyl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; Cefprozilum; Cefprozil anhydrous |
Purity(HPLC) | ≥98%(Cefprozil (Z)-Isomer + Cefprozil (E)-Isomer); (E)-isomer ratio=(E/(E+Z)), the ratio is between 0.06 and 0.11; | CAS Number | 92665-29-7 |
Formula | C18H19N3O5S | Molecular Weight | 389.43 |
Suitability | BioReagent, suitable for cell culture, etc. |
l Physical and Chemical Information |
Appearance | Off-white or pale yellow solid |
Solubility(25℃) | DMSO | ≥25mg/mL |
Ethanol | ≥10mg/mL |
Water | Slightly soluble |
l Biological Information |
Biochem/Physiol Actions | Cefprozil is a semi-synthetic cephalosporin and a beta-lactam antibiotic with bactericidal activity. Cefprozil's effect is dependent on its binding to penicillin-binding proteins (PBPs) located in the bacterial cytoplasmic membrane. Binding results in the inhibition of the transpeptidase enzymes, thereby preventing cross-ing of the pentaglycine bridge with the fourth residue of the pentapeptide and interrupting consequent synthesis of peptidoglycan chains. As a result, cefprozil inhibits bacterial septum and cell wall synthesis formation. |
Application | Anti-Bacterial Agents |
l Packaging & Storage |
Packaging | 25mg; 100mg; 250mg |
Storage temp. | -20℃ |
l Precautions and Disclaimer |
This product is for R&D use only, not for drug, household, or other uses. |
l References |
1. http://www.drugbank.ca 2. https://ncit.nci.nih.gov 3. https://www.ncbi.nlm.nih.gov |